- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us
od Transfusions
Information about West Nile Virus and Blood Safety
Background
The ongoing outbreak of West Nile virus (WNV) infections in the United States has raised concern that WNV could be transmitted through blood transfusion. No cases of WNV attributed to transfusion of blood or blood products have been reported to date in the United States or elsewhere. Available data indicate a theoretical, albeit small, risk of WNV transmission from transfusion of blood.
FDA Blood Safety Provisions
Donor Deferral
nd 2012
CONGRESSIONAL BUDGET OFFICE
PAY-AS-YOU-GO ESTIMATE
July 8, 2002
H.R. 3448
Public Health Security and Bioterrorism Preparedness and Response Act of 2002
As cleared by the Congress on May 23, 2002, with corrections adopted in S. Con. Res. 117 on June 4, 2002, and signed by the President on June 12, 2002
SUMMARY
ys
[Federal Register: August 19, 2002 (Volume 67, Number 160)]
[Notices]
[Page 53805-53806]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr19au02-71]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 02N-0354]
Agency Emergency Processing under OMB Review; The Evaluation of Long-Term Antibiotic Drug Therapy for Persons Involved in Anthrax Remediation Activities
/index.php?option=com_iwpfile&file=/dir_01/he2002_2202.pdf
ts
NATIONAL INSTITUTES OF HEALTH
National Heart, Lung, and Blood Institute
NIH NEWS ADVISORY
FOR IMMEDIATE RELEASE
Monday, August 19, 2002
Press Contact: NHLBI Communications Office
(301) 496-4236
NIH TO HOLD WORKSHOP ON CARDIOVASCULAR EFFECTS OF SEVERAL WIDELY USED HERBAL DIETARY SUPPLEMENTS
on
Metabolife sent a similar letter to the California's Department of Health Service in May 1996. Dec 21 Letter To HHS Metabolife California Letter
56
Steven Karch, cardiac pathology and cardiac toxicology specialist, Ashraf Mozayani, chief toxicologist and laboratory director in the Harris County Medical Examiner's Office, and Craig Molgaard, professor of preventive medicine at the University of Kansas, issued reports on Metabolife 356 concluding that "there is no demonstrable connection between use of Metabolife 356 and any of the conditions reported by the Health Line callers" and "Health Line reports support a favorable safety profile of Metabolife 356."
